Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease-Reference-Cited by-同舟云学术

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

Published:2006-03 Issue:3 Volume:63 Page:433-442
ISSN:0016-5107
Container-title:Gastrointestinal Endoscopy
language:en
Short-container-title:Gastrointestinal Endoscopy

Author:

Rutgeerts Paul,Diamond Robert H.,Bala Mohan,Olson Allan,Lichtenstein Gary R.,Bao Weihang,Patel Kamlesh,Wolf Douglas C.,Safdi Michael,Colombel Jean Frederic,Lashner Bret,Hanauer Stephen B.

Publisher

Elsevier BV

Subject

Gastroenterology,Radiology Nuclear Medicine and imaging

Reference25 articles.

1. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection;Kindler;Cell,1989

2. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation;Braegger;Lancet,1992

3. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease;Breese;Gastroenterology,1994

4. Tumor necrosis factor-alpha and interferon gamma production measured at the single cell level in normal and inflamed human intestine;MacDonald;Clin Exp Immunol,1990

5. Tumor necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease;Schreiber;Lancet,1999

Cited by 492 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment;Journal of Crohn's and Colitis;2024-06-15

3. Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn’s Disease: A Systematic Review and Network Meta-Analysis;Clinical Gastroenterology and Hepatology;2024-06

4. Anti–Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease;JAMA Network Open;2024-04-16

5. Infliximab for maintenance of medically-induced remission in Crohn's disease;Cochrane Database of Systematic Reviews;2024-02-19